KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) EBITDA Margin (2018 - 2025)

Historic EBITDA Margin for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to 29.37%.

  • Twist Bioscience's EBITDA Margin rose 63900.0% to 29.37% in Q4 2025 from the same period last year, while for Dec 2025 it was 19.53%, marking a year-over-year increase of 402500.0%. This contributed to the annual value of 20.65% for FY2025, which is 459600.0% up from last year.
  • Per Twist Bioscience's latest filing, its EBITDA Margin stood at 29.37% for Q4 2025, which was up 63900.0% from 27.17% recorded in Q3 2025.
  • In the past 5 years, Twist Bioscience's EBITDA Margin ranged from a high of 21.02% in Q2 2025 and a low of 127.8% during Q1 2022
  • For the 5-year period, Twist Bioscience's EBITDA Margin averaged around 74.77%, with its median value being 84.69% (2022).
  • Its EBITDA Margin has fluctuated over the past 5 years, first plummeted by -332300bps in 2021, then surged by 1261500bps in 2025.
  • Twist Bioscience's EBITDA Margin (Quarter) stood at 108.0% in 2021, then grew by 27bps to 79.38% in 2022, then increased by 25bps to 59.89% in 2023, then soared by 40bps to 35.76% in 2024, then rose by 18bps to 29.37% in 2025.
  • Its EBITDA Margin stands at 29.37% for Q4 2025, versus 27.17% for Q3 2025 and 21.02% for Q2 2025.